Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
Despite constituting approximately two thirds of all breast cancers, the luminal A and B tumours are poorly classified at both clinical and molecular levels.There are contradictory reports on the nature of these subtypes: some define them as intrinsic entities, others as a continuum.With the aim of addressing these uncertainties and identifying mol